vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $617.8M, roughly 1.5× Hims & Hers Health, Inc.). Hims & Hers Health, Inc. runs the higher net margin — 3.3% vs 0.7%, a 2.6% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 28.4%). Hims & Hers Health, Inc. produced more free cash flow last quarter ($-2.5M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 49.0%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
ASTH vs HIMS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $617.8M |
| Net Profit | $6.6M | $20.6M |
| Gross Margin | — | 71.9% |
| Operating Margin | 1.9% | 1.5% |
| Net Margin | 0.7% | 3.3% |
| Revenue YoY | 42.9% | 28.4% |
| Net Profit YoY | 184.4% | -20.8% |
| EPS (diluted) | $0.12 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $617.8M | ||
| Q3 25 | $956.0M | $599.0M | ||
| Q2 25 | $654.8M | $544.8M | ||
| Q1 25 | $620.4M | $586.0M | ||
| Q4 24 | $665.2M | $481.1M | ||
| Q3 24 | $478.7M | $401.6M | ||
| Q2 24 | $486.3M | $315.6M | ||
| Q1 24 | $404.4M | $278.2M |
| Q4 25 | $6.6M | $20.6M | ||
| Q3 25 | $373.0K | $15.8M | ||
| Q2 25 | $9.4M | $42.5M | ||
| Q1 25 | $6.7M | $49.5M | ||
| Q4 24 | $-7.8M | $26.0M | ||
| Q3 24 | $16.1M | $75.6M | ||
| Q2 24 | $19.2M | $13.3M | ||
| Q1 24 | $14.8M | $11.1M |
| Q4 25 | — | 71.9% | ||
| Q3 25 | — | 73.8% | ||
| Q2 25 | — | 76.4% | ||
| Q1 25 | — | 73.5% | ||
| Q4 24 | — | 76.8% | ||
| Q3 24 | — | 79.2% | ||
| Q2 24 | — | 81.3% | ||
| Q1 24 | — | 82.4% |
| Q4 25 | 1.9% | 1.5% | ||
| Q3 25 | 2.0% | 2.0% | ||
| Q2 25 | 3.1% | 4.9% | ||
| Q1 25 | 3.3% | 9.9% | ||
| Q4 24 | 0.1% | 3.9% | ||
| Q3 24 | 5.9% | 5.6% | ||
| Q2 24 | 6.2% | 3.5% | ||
| Q1 24 | 7.5% | 3.6% |
| Q4 25 | 0.7% | 3.3% | ||
| Q3 25 | 0.0% | 2.6% | ||
| Q2 25 | 1.4% | 7.8% | ||
| Q1 25 | 1.1% | 8.4% | ||
| Q4 24 | -1.2% | 5.4% | ||
| Q3 24 | 3.4% | 18.8% | ||
| Q2 24 | 3.9% | 4.2% | ||
| Q1 24 | 3.7% | 4.0% |
| Q4 25 | $0.12 | $0.08 | ||
| Q3 25 | $0.01 | $0.06 | ||
| Q2 25 | $0.19 | $0.17 | ||
| Q1 25 | $0.14 | $0.20 | ||
| Q4 24 | $-0.14 | $0.10 | ||
| Q3 24 | $0.33 | $0.32 | ||
| Q2 24 | $0.40 | $0.06 | ||
| Q1 24 | $0.31 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $228.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $540.9M |
| Total Assets | $2.2B | $2.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $228.6M | ||
| Q3 25 | $463.4M | $345.8M | ||
| Q2 25 | $342.1M | $1.1B | ||
| Q1 25 | $260.9M | $273.7M | ||
| Q4 24 | $290.8M | $220.6M | ||
| Q3 24 | $350.3M | $165.5M | ||
| Q2 24 | $327.7M | $129.3M | ||
| Q1 24 | $337.3M | $105.2M |
| Q4 25 | $779.3M | $540.9M | ||
| Q3 25 | $775.5M | $581.0M | ||
| Q2 25 | $765.5M | $562.7M | ||
| Q1 25 | $745.4M | $549.3M | ||
| Q4 24 | $712.7M | $476.7M | ||
| Q3 24 | $704.6M | $440.1M | ||
| Q2 24 | $678.9M | $362.0M | ||
| Q1 24 | $653.5M | $344.5M |
| Q4 25 | $2.2B | $2.2B | ||
| Q3 25 | $2.2B | $2.2B | ||
| Q2 25 | $1.4B | $1.9B | ||
| Q1 25 | $1.3B | $891.7M | ||
| Q4 24 | $1.4B | $707.5M | ||
| Q3 24 | $1.3B | $602.3M | ||
| Q2 24 | $1.3B | $480.5M | ||
| Q1 24 | $1.2B | $448.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $61.3M |
| Free Cash FlowOCF − Capex | $-6.0M | $-2.5M |
| FCF MarginFCF / Revenue | -0.6% | -0.4% |
| Capex IntensityCapex / Revenue | 0.3% | 10.3% |
| Cash ConversionOCF / Net Profit | -0.44× | 2.98× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $57.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $61.3M | ||
| Q3 25 | $10.0M | $148.7M | ||
| Q2 25 | $90.9M | $-19.1M | ||
| Q1 25 | $16.6M | $109.1M | ||
| Q4 24 | $-10.9M | $86.4M | ||
| Q3 24 | $34.0M | $85.3M | ||
| Q2 24 | $23.2M | $53.6M | ||
| Q1 24 | $6.0M | $25.8M |
| Q4 25 | $-6.0M | $-2.5M | ||
| Q3 25 | $7.4M | $79.3M | ||
| Q2 25 | $89.5M | $-69.5M | ||
| Q1 25 | $13.6M | $50.1M | ||
| Q4 24 | $-13.5M | $59.5M | ||
| Q3 24 | $31.7M | $79.4M | ||
| Q2 24 | $20.4M | $47.6M | ||
| Q1 24 | $5.6M | $11.8M |
| Q4 25 | -0.6% | -0.4% | ||
| Q3 25 | 0.8% | 13.2% | ||
| Q2 25 | 13.7% | -12.8% | ||
| Q1 25 | 2.2% | 8.5% | ||
| Q4 24 | -2.0% | 12.4% | ||
| Q3 24 | 6.6% | 19.8% | ||
| Q2 24 | 4.2% | 15.1% | ||
| Q1 24 | 1.4% | 4.3% |
| Q4 25 | 0.3% | 10.3% | ||
| Q3 25 | 0.3% | 11.6% | ||
| Q2 25 | 0.2% | 9.3% | ||
| Q1 25 | 0.5% | 10.1% | ||
| Q4 24 | 0.4% | 5.6% | ||
| Q3 24 | 0.5% | 1.5% | ||
| Q2 24 | 0.6% | 1.9% | ||
| Q1 24 | 0.1% | 5.0% |
| Q4 25 | -0.44× | 2.98× | ||
| Q3 25 | 26.69× | 9.43× | ||
| Q2 25 | 9.65× | -0.45× | ||
| Q1 25 | 2.48× | 2.20× | ||
| Q4 24 | — | 3.32× | ||
| Q3 24 | 2.11× | 1.13× | ||
| Q2 24 | 1.21× | 4.03× | ||
| Q1 24 | 0.40× | 2.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
HIMS
Segment breakdown not available.
